Evidence map›Paper›PMID 35874748›Full record

ArticleFrontiers in immunology2022

Sortase A-Cleavable CD1d Identifies Sphingomyelins as Major Class of CD1d-Associated Lipids.

Maren Rudolph, Yuting Wang, Theresa Simolka, Emilie Huc-Claustre, Lingyun Dai, Gijsbert Grotenbreg, Gurdyal Singh Besra, Anna Shevchenko, Andrej Shevchenko, Sebastian Zeissig

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Sideways lipid presentation by the antigen-presenting molecule CD1c.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Lipidomic scanning of self-lipids identifies headless antigens for natural killer T cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Insights into the CD1 lipidome.Frontiers in immunology · 2024
    Article
  6. Article
  7. Review
  8. CD1 displays its own negative regulators.Current opinion in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Maren RudolphDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Yuting WangDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Theresa SimolkaDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Emilie Huc-ClaustreDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Lingyun DaiDepartment of Geriatrics, First Affiliated Hospital of Southern University of Science and Technology (Shenzhen People's Hospital), Shenzhen, China.
Gijsbert GrotenbregMaze Therapeutics, South San Francisco, CA, United States.
Gurdyal Singh BesraSchool of Biosciences, University of Birmingham, Birmingham, United Kingdom.
Anna ShevchenkoMax Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
Andrej ShevchenkoMax Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
Sebastian ZeissigDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
TU Dresden · DEMax Planck Institute of Molecular Cell Biology and Genetics · DEMaze (United States) · USSouthern University of Science and Technology · CNUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD1d is an atypical MHC class I molecule which binds endogenous and exogenous lipids and can activate natural killer T (NKT) cells through the presentation of lipid antigens. CD1d surveys different cellular compartments including the secretory and the endolysosomal pathway and broadly binds lipids through its two hydrophobic pockets. Purification of the transmembrane protein CD1d for the analysis of bound lipids is technically challenging as the use of detergents releases CD1d-bound lipids. To address these challenges, we have developed a novel approach based on Sortase A-dependent enzymatic release of CD1d at the cell surface of live mammalian cells, which allows for single step release and affinity tagging of CD1d for shotgun lipidomics. Using this system, we demonstrate that CD1d carrying the Sortase A recognition motif shows unimpaired subcellular trafficking through the secretory and endolysosomal pathway and is able to load lipids in these compartments and present them to NKT cells. Comprehensive shotgun lipidomics demonstrated that the spectrum and abundance of CD1d-associated lipids is not representative of the total cellular lipidome but rather characterized by preferential binding to long chain sphingolipids and glycerophospholipids. As such, sphingomyelin species recently identified as critical negative regulators of NKT cell activation, represented the vast majority of endogenous CD1d-associated lipids. Moreover, we observed that inhibition of endolysosomal trafficking of CD1d surprisingly did not affect the spectrum of CD1d-bound lipids, suggesting that the majority of endogenous CD1d-associated lipids load onto CD1d in the secretory rather than the endolysosomal pathway. In conclusion, we present a novel system for the analysis of CD1d-bound lipids in mammalian cells and provide new insight into the spectrum of CD1d-associated lipids, with important functional implications for NKT cell activation.

Indexed as

AminoacyltransferasesSphingomyelinsAnimalsAntigens, CD1dBacterial ProteinsCysteine EndopeptidasesMammalsAminoacyltransferasesAntigens, CD1dBacterial ProteinsCysteine Endopeptidasessortase ASphingomyelinsCD1dNKT cellshotgun lipidomicsSortase Asphingomyelin

Identifiers

PMID35874748
PMCPMC9301999
OpenAlexW4288064388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.